SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) Primer on Tumor Immunology and Cancer Immunotherapy^TM - From Biology to Treatment
June 1, 2012
Hyatt Regency McCormick Place
Chicago, IL

Program Organizers
Kim A. Margolin, MD - Seattle Cancer Care Alliance
Walter J. Urba, MD, PhD - Earle A Chiles Research Institute

Program Summary
The SITC Primer on Tumor Immunology and Cancer Immunotherapy^TM From Biology to Treatment is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunology and the immunotherapy of malignancy. It aims to advance successful immune-base treatments provided by practicing oncologists quickly and efficiently in point-of-care patient applications for positive outcomes.

Prominent investigators will summarize central themes and recent research advances in such areas as innate immunity and inflammation in cancer biology, dendritic cells, T cell function, antibody therapy, and the host-tumor relationship as well as recent advances in the clinical application of cancer vaccines, coinhibition and costimulation of immune cells , and adoptive cellular therapy of cancer.

Target Audience
The audience for this half-day educational program is clinical oncologists working directly with patients as well as other oncology health care practitioners who wish to solidify their understanding of recent advances and the biologic basis of tumor immunology and immunotherapy. In addition, other audience who would find this program of value are basic scientists and clinical investigators (clinicians, researchers, graduate students, postdoctoral fellows, and allied health professionals) from academic institutions, industry, and regulatory agencies.

Presentations and video recordings are available based on permission from presenters.